(Reuters) -Eli Lilly said on Wednesday its experimental pill, orforglipron, helped reduce blood sugar levels in two late-stage trials. The oral drug is designed to mimic the appetite-suppressing GLP-1 hormone …
Copyright MatchingDonors.com©️ 2025 All rights reserved.